PTCTPTC THERAPEUTICS, INC.同业对比
PTC THERAPEUTICS, INC. 与SPDR S&P Biotech ETF 持仓的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:XBI 前十大持仓| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PTCT本股 | $5.5B#9 | — | — | 3.2x#1 | 114.5%#3 | 288.0%#1 | 50.1%#1 | — | — | — | — | — |
| TWST | $10.5B#2 | — | 23.5x#9 | 27.8x#2 | 20.3%#5 | 62.8%#2 | -36.2%#2 | -17.4%#6 | -41.4%#2 | — | 497.4%#3 | — |
| ORKA | $6.3B#8 | — | 5.6x#2 | — | — | -25.9%#6 | — | -9.5%#3 | — | — | 472.3%#4 | — |
| KYMR | $9.8B#3 | — | 6.5x#5 | 249.8x#5 | -16.7%#6 | 39.1%#3 | -891.1%#5 | 20.6%#1 | — | — | 130.3%#6 | — |
| VKTX | $3.4B#12 | — | 8.3x#6 | — | — | -227.1%#12 | — | -88.1%#10 | — | — | 11.3%#9 | — |
| PRAX | $8.4B#5 | — | 6.2x#3 | — | -100.0%#8 | -65.6%#8 | — | -22.6%#7 | — | — | 561.0%#2 | — |
| ERAS | $5.2B#11 | — | 14.3x#7 | — | — | 23.0%#5 | — | -34.4%#8 | — | — | 688.8%#1 | — |
| RVMD | $40.9B#1 | — | 15.7x#8 | — | — | -88.5%#10 | — | -43.4%#9 | — | — | 321.9%#5 | — |
| RYTM | $6.7B#6 | — | 65.2x#10 | 35.4x#3 | 45.8%#4 | 24.6%#4 | -101.2%#3 | -0.2%#2 | -133.8%#3 | — | -1.1%#10 | — |
| CGON | $6.6B#7 | — | 6.4x#4 | 1639.6x#6 | 254.7%#2 | -82.9%#9 | -4722.1%#6 | -15.6%#5 | -18.8%#1 | — | 92.5%#7 | — |
| DNTH | $5.4B#10 | — | 4.6x#1 | 2659.6x#7 | -67.3%#7 | -91.1%#11 | -8739.3%#7 | -13.9%#4 | — | — | — | — |
| CYTK | $9.6B#4 | — | — | 108.5x#4 | 376.6%#1 | -33.2%#7 | -695.4%#4 | — | — | — | 39.3%#8 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-19。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议